ADVENZYMES - Advanced Enzyme Technologies Limited Share Price

Pharmaceuticals & Biotechnology

Sharesguru Stock Score

ADVENZYMES

55/100

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years

₹324.35-5.45(-1.65%)

Market Closed as of Aug 7, 2026, 15:30 IST

Select time range

Pros

Profitability: Very strong Profitability. One year profit margin are 22%.

Balance Sheet: Strong Balance Sheet.

Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.

Technicals: Bullish SharesGuru indicator.

Growth: Good revenue growth. With 32.1% growth over past three years, the company is going strong.

Buy Backs: Company has bought back it's stock in the past which is a good thing.

Cons

Past Returns: Underperforming stock! In past three years, the stock has provided -1% return compared to 7.9% by NIFTY 50.

Valuation
Market Cap	3.63 kCr
Price/Earnings (Trailing)	21.89
Price/Sales (Trailing)	4.61
EV/EBITDA	12.94
Price/Free Cashflow	34.74
MarketCap/EBT	15.71
Enterprise Value	3.54 kCr

Fundamentals
Revenue (TTM)	788.63 Cr
Rev. Growth (Yr)	4.1%
Earnings (TTM)	171.76 Cr
Earnings Growth (Yr)	-4.6%

Profitability
Operating Margin	28%
EBT Margin	29%
Return on Equity	10.2%
Return on Assets	9.34%
Free Cashflow Yield	2.88%

Growth & Returns
Price Change 1W	2.9%
Price Change 1M	1.8%
Price Change 6M	12.8%
Price Change 1Y	3.9%
3Y Cumulative Return	-1%
5Y Cumulative Return	-4.7%
7Y Cumulative Return	11.1%
10Y Cumulative Return	1%

Cash Flow & Liquidity
Cash Flow from Investing (TTM)	-74.13 Cr
Cash Flow from Operations (TTM)	156.78 Cr
Cash Flow from Financing (TTM)	-70.37 Cr
Cash & Equivalents	108.75 Cr
Free Cash Flow (TTM)	104.55 Cr
Free Cash Flow/Share (TTM)	9.34

Balance Sheet
Total Assets	1.84 kCr
Total Liabilities	155.64 Cr
Shareholder Equity	1.68 kCr
Current Assets	1.04 kCr
Current Liabilities	106.72 Cr
Net PPE	275.83 Cr
Inventory	177.28 Cr
Goodwill	369.46 Cr

Capital Structure & Leverage
Debt Ratio	0.01
Debt/Equity	0.01
Interest Coverage	93.62
Interest/Cashflow Ops	65.17

Dividend & Shareholder Returns
Dividend/Share (TTM)	1.35
Dividend Yield	0.42%
Shares Dilution (1Y)	0.10%
Shares Dilution (3Y)	0.10%

Technical Indicators
RSI (14d)	54.19
RSI (5d)	66.37
RSI (21d)	50
MACD Signal	Buy
Stochastic Oscillator Signal	Hold
SharesGuru Signal	Buy
RSI Signal	Hold
RSI5 Signal	Hold
RSI21 Signal	Hold
SMA 5 Signal	Sell
SMA 10 Signal	Buy
SMA 20 Signal	Buy
SMA 50 Signal	Sell
SMA 100 Signal	Sell

Shareholder Name	Holding %
Vasant Rathi	26.68%
Orbimed Asia III Mauritius FVCI Limited	12.06%
Nalanda India Equity Fund Limited	8.45%
Vasant and Prabha Rathi Generation Trust	6.7%
Polunin Emerging Markets Small Cap Fund, LLC	2.46%
Rasika Vasant Rathi	2.38%
Rachana Vasant Rathi	2.36%
Reshma Namita Rathi	2.36%
Clarus Capital I	2.28%
Marval Guru Fund	1.79%
Pradip Bhailal Shah	1.66%
Mukund Madhusudan Kabra	1.63%
Kishor Laxminarayan Rathi HUF	0.98%
Prabhavati Vasant Rathi	0.82%
Madhusudan Kabra	0.55%
Kishor Laxminarayan Rathi	0.36%
Megha Jhawar	0.01%
Jayesh Madhusudan Soni	0.01%
Shruti Sharad Dhamdhere	0.01%
Pratik Prakash Kokane	0.01%

Ticker	Name	Mkt Cap	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
BIOCON	Biocon	69.48 kCr	17.64 kCr	+7.40%	+17.10%	125.4	3.94	-	-
SEQUENT	Sequent Scientific	12.1 kCr	2.68 kCr	+2.40%	+58.30%	85.23	4.52	-	-
NEOGEN	Neogen Chemicals	5.56 kCr	934.35 Cr	+4.20%	+43.50%	152.89	5.95	-	-
AARTIDRUGS	Aarti Drugs	3.8 kCr	2.68 kCr	+7.50%	-17.80%	19.89	1.42	-	-
ROSSARI	ROSSARI BIOTECH	2.85 kCr	2.57 kCr	+1.80%	-21.80%	18.86	1.11	-	-

Description	(%) Q/Q	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Revenue From Operations	17.1%	746	637	624	541	529	502
Other Income	6.2%	35	33	37	25	6.42	8.85
Total Income	16.6%	781	670	661	566	536	511
Cost of Materials	19.9%	194	162	155	128	130	100
Purchases of stock-in-trade	-	0	0	0.02	0.02	0.07	0.03
Employee Expense	14.2%	162	142	128	115	104	87
Finance costs	-36.3%	2.63	3.56	2.93	2.42	1.8	1.59
Depreciation and Amortization	8.3%	40	37	35	35	35	28
Other expenses	8.1%	161	149	146	138	114	84
Total Expenses	15.8%	559	483	458	422	365	300
Profit Before exceptional items and Tax	18.3%	221	187	203	144	171	210
Exceptional items before tax	-	11	0	-15.13	-4.06	0	0
Total profit before tax	24.7%	233	187	188	140	171	210
Current tax	12.2%	56	50	56	43	50	58
Deferred tax	-48.3%	2.48	3.86	-5.33	-6.34	-3.1	0.95
Total tax	11.5%	59	53	51	37	47	59
Total profit (loss) for period	30.1%	174	134	137	104	124	151
Other comp. income net of taxes	422.2%	95	19	9.25	55	17	-9.93
Total Comprehensive Income	75.7%	268	153	146	158	140	142
Earnings Per Share, Basic	31.3%	15.08	11.72	11.92	9.45	10.7	13.09
Earnings Per Share, Diluted	31.3%	15.06	11.71	11.92	9.45	10.68	13.07
Debt equity ratio	0%	001	002	0	-	001	002
Debt service coverage ratio	2.2%	0.0815	0.0611	-	-	-	-
Interest service coverage ratio	48.5%	0.7105	0.4377	-	-	-	-

Description	(%) Q/Q	Jun-2026	Mar-2026	Dec-2025	Sep-2025	Jun-2025	Mar-2025
Revenue From Operations	-6.4%	190	203	172	185	186	167
Other Income	92.6%	13	7.23	8.47	10	8.85	8.74
Total Income	-3.8%	203	211	180	195	195	176
Cost of Materials	-3.6%	54	56	46	49	44	46
Employee Expense	7.3%	45	42	41	39	40	37
Finance costs	2.3%	0.58	0.57	0.57	0.72	0.76	0.81
Depreciation and Amortization	-1.3%	9.88	10	10	10	9.62	10
Other expenses	10%	45	41	40	41	40	39
Total Expenses	-1.3%	149	151	133	135	140	132
Profit Before exceptional items and Tax	-10.2%	54	60	47	60	55	43
Exceptional items before tax	-12.4%	0	0.11	11	0	0	0
Total profit before tax	-10.2%	54	60	58	60	55	43
Current tax	16.7%	15	13	12	16	15	14
Deferred tax	-665%	-0.13	1.2	3.17	-0.88	-1.01	2.58
Total tax	0%	15	15	15	15	14	17
Total profit (loss) for period	-13.6%	39	45	43	45	40	27
Other comp. income net of taxes	-105.2%	-1.43	48	12	31	3.77	0.66
Total Comprehensive Income	-60.9%	37	93	55	76	44	27
Earnings Per Share, Basic	-18.7%	3.31	3.84	3.8	3.87	3.57	2.37
Earnings Per Share, Diluted	-18.7%	3.31	3.84	3.79	3.87	3.57	2.37
Debt equity ratio	0%	001	001	001	001	002	002
Debt service coverage ratio	-1.1%	0.0823	0.0927	0.0968	0.0862	0.0696	0.0554
Interest service coverage ratio	-226.6%	0.7005	0.9083	0.6791	0.6874	0.6065	0.4143

Description	(%) Q/Q	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Revenue From Operations	29.1%	453	351	365	312	273	283
Other Income	3.3%	63	61	59	9.81	9.08	6.82
Total Income	25%	516	413	424	321	282	290
Cost of Materials	26.4%	188	149	140	121	113	95
Employee Expense	16.4%	65	56	50	41	39	34
Finance costs	-3.9%	0.21	0.24	0.16	0.14	0.1	0.08
Depreciation and Amortization	10%	12	11	11	10	9.56	8.93
Other expenses	13.6%	93	82	79	72	62	52
Total Expenses	21.6%	355	292	271	247	210	192
Profit Before exceptional items and Tax	34.2%	162	121	153	74	72	98
Exceptional items before tax	-	-3.86	0	-18.95	0	0	0
Total profit before tax	30.8%	158	121	134	74	72	98
Current tax	62.5%	27	17	27	18	18	25
Deferred tax	-1100%	-1.2	1.22	-1.08	0.5	-0.46	2.57
Total tax	47.1%	26	18	26	19	18	27
Total profit (loss) for period	29.7%	132	102	108	56	55	71
Other comp. income net of taxes	88.1%	0.84	-0.34	-0.1	0.49	0.02	-0.03
Total Comprehensive Income	30.7%	133	102	108	56	55	71
Earnings Per Share, Basic	32.1%	11.78	9.16	9.67	4.97	4.88	6.36
Earnings Per Share, Diluted	32%	11.76	9.15	9.66	4.97	4.87	6.35
Debt equity ratio	-	0	-	0	-	0	0
Debt service coverage ratio	-	-	-	-	-	-	-

Description	(%) Q/Q	Jun-2026	Mar-2026	Dec-2025	Sep-2025	Jun-2025	Mar-2025
Revenue From Operations	0%	116	116	96	116	125	87
Other Income	-69%	2.29	5.16	1.29	3.08	54	4.53
Total Income	-3.3%	118	122	97	119	179	92
Cost of Materials	-4.1%	48	50	37	48	52	38
Employee Expense	13.3%	18	16	16	16	16	15
Finance costs	-2.1%	0.04	0.06	0.04	0.05	0.05	0.08
Depreciation and Amortization	-9.4%	2.92	3.12	3.04	3	2.93	3.11
Other expenses	4.2%	26	25	22	24	22	20
Total Expenses	-5.4%	88	93	75	89	97	76
Profit Before exceptional items and Tax	3.6%	30	29	22	30	81	16
Exceptional items before tax	-	0	0	-3.86	0	0	0
Total profit before tax	3.6%	30	29	18	30	81	16
Current tax	-1.9%	6.66	6.77	5.58	7.28	7.44	3.54
Deferred tax	77.9%	0.73	-0.22	-1.01	0.05	-0.03	0.91
Total tax	15.1%	7.39	6.55	4.57	7.34	7.42	4.46
Total profit (loss) for period	0%	22	22	13	22	74	11
Other comp. income net of taxes	-81.8%	0	0.45	0.39	0	0	-0.34
Total Comprehensive Income	-4.5%	22	23	14	22	74	11
Earnings Per Share, Basic	1%	2	1.99	1.18	1.99	6.61	0.99
Earnings Per Share, Diluted	0%	1.99	1.99	1.18	1.99	6.61	0.99
Debt service coverage ratio	-	7.4949	-	4.5436	5.4057	5.1814	-
Interest service coverage ratio	-	7.4949	-	4.5436	5.4057	5.1814	-

Description	(%) Q/Q	Mar-2026	Sep-2025	Mar-2025	Sep-2024	Mar-2024	Sep-2023
Cash and cash equivalents	77%	109	62	94	98	114	100
Current investments	10.4%	584	529	480	396	403	342
Loans, current	-5.6%	0.24	0.28	0.1	0.12	0.1	0.14
Total current financial assets	14.7%	854	745	711	621	648	584
Inventories	2.3%	177	173	157	168	148	136
Current tax assets	-	13	0	0	1.77	0.27	1.02
Total current assets	11.9%	1,044	933	880	807	810	737
Property, plant and equipment	-2.8%	276	284	293	281	277	273
Capital work-in-progress	66.7%	51	31	22	34	31	17
Goodwill	6.1%	369	348	333	328	325	324
Non-current investments	0%	0.06	0.06	0.06	0.16	0.16	0.16
Loans, non-current	-	0.1	0	0.06	0	0.04	0
Total non-current financial assets	171.2%	9.84	4.26	10	4.52	4.4	4.68
Total non-current assets	4.9%	795	758	741	742	726	707
Total assets	8.7%	1,839	1,692	1,621	1,549	1,535	1,444
Borrowings, non-current	-10.4%	7.89	8.69	9.18	6.68	6.96	7.41
Total non-current financial liabilities	-26.7%	12	16	21	21	23	21
Provisions, non-current	398.9%	5.39	1.88	1.37	1.14	0.89	0.58
Total non-current liabilities	-5.9%	49	52	56	56	58	58
Borrowings, current	20%	13	11	12	19	18	13
Total current financial liabilities	22.2%	89	73	62	70	64	72
Provisions, current	-71.6%	6.39	20	21	19	20	2.72
Current tax liabilities	-96.7%	1.01	1.3	4.59	0.59	9.14	3.32
Total current liabilities	0%	107	107	97	104	106	87
Total liabilities	-1.3%	156	158	153	160	164	145
Equity share capital	0%	22	22	22	22	22	22
Non controlling interest	4.2%	51	49	48	47	47	50
Total equity	9.7%	1,683	1,534	1,469	1,389	1,371	1,299
Total equity and liabilities	8.7%	1,839	1,692	1,621	1,549	1,535	1,444

Description	(%) Q/Q	Mar-2026	Sep-2025	Mar-2025	Sep-2024	Mar-2024	Sep-2023
Cash and cash equivalents	-86.2%	1.89	7.46	5.6	7.26	1.5	2.73
Current investments	66.7%	91	55	37	48	51	25
Loans, current	0%	0.15	0.15	0.03	0.04	0.04	0.08
Total current financial assets	9.7%	194	177	126	138	145	126
Inventories	13.7%	117	103	101	115	97	90
Total current assets	9.8%	316	288	232	261	248	222
Property, plant and equipment	-1.4%	145	147	151	146	142	141
Capital work-in-progress	60%	49	31	21	21	16	9.25
Non-current investments	0%	254	254	254	206	205	218
Loans, non-current	9.1%	0.1	0.01	0.06	0	0.04	0.51
Total non-current financial assets	7.4%	276	257	279	208	208	221
Total non-current assets	5.9%	488	461	456	404	385	397
Total assets	7.4%	804	749	689	666	633	619
Total non-current financial liabilities	-	1.03	0	1.97	2.46	0	1.27
Provisions, non-current	1317.4%	4.26	1.23	0.82	0.66	0.66	0.32
Total non-current liabilities	7.1%	16	15	15	14	12	13
Borrowings, current	-	0	0	0	0	0	0
Total current financial liabilities	28.8%	68	53	37	39	34	46
Provisions, current	58.3%	3.77	2.75	3.54	1.64	2.54	1.62
Current tax liabilities	0%	0.29	0.29	0.29	0.29	0.29	0.29
Total current liabilities	22.2%	78	64	45	49	40	50
Total liabilities	20.8%	94	78	59	63	52	63
Equity share capital	0%	22	22	22	22	22	22
Total equity	5.8%	710	671	629	602	580	556
Total equity and liabilities	7.4%	804	749	689	666	633	619

Description	(%) Q/Q	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Finance costs	85.9%	0	-6.1	0	0	0	-
Change in inventories	-96%	-16.25	-7.8	-23.83	0.76	-26.1	-
Depreciation	8.3%	40	37	35	35	35	-
Unrealised forex losses/gains	-32.4%	-0.43	-0.08	-0.08	-0.11	-0.01	-
Adjustments for interest income	-	0	0	0	0	1.13	-
Share-based payments	57.6%	4.86	3.45	0	0	0	-
Net Cashflows from Operations	17.9%	238	202	201	183	175	-
Interest paid	-	-2.63	0	-2.93	-2.42	-1.79	-
Interest received	-	-18.66	0	-12.97	-8.42	1.23	-
Income taxes paid (refund)	8.5%	65	60	49	37	55	-
Net Cashflows From Operating Activities	10.6%	157	142	141	140	124	-
Proceeds from sales of PPE	-17%	0.45	0.53	0.16	0.25	1.3	-
Purchase of property, plant and equipment	54.5%	52	34	42	38	28	-
Purchase of investment property	-	0	0	0	0	21	-
Proceeds from sales of intangible assets	-	0	0	0	0	22	-
Purchase of intangible assets	-2733.3%	0.15	0.97	0.05	0.08	0.06	-
Purchase of intangible assets under development	-	0	0	4.95	0	0	-
Interest received	90.2%	18	9.94	13	7.87	0	-
Other inflows (outflows) of cash	37.1%	-40.41	-64.79	-30.43	-268.12	-0.24	-
Net Cashflows From Investing Activities	16.6%	-74.13	-89.1	-64.65	-298.18	-26.14	-
Proceeds from issuing shares	91.9%	0.95	0.38	0	0.14	0.43	-
Proceeds from borrowings	85.3%	0	-5.81	0	0	0.67	-
Repayments of borrowings	100.3%	1.01	-2.23	-12.05	0.32	8.81	-
Payments of lease liabilities	-	0	0	6.05	6.48	6.04	-
Dividends paid	1.7%	60	59	57	13	0	-
Interest paid	-39.3%	2.42	3.34	2.92	2.42	1.78	-
Other inflows (outflows) of cash	-14.3%	-8.11	-6.97	-5.61	-4.18	-11.86	-
Net Cashflows from Financing Activities	3%	-70.37	-72.54	-59.24	-25.8	-27.38	-
Effect of exchange rate on cash eq.	190.6%	2.25	-0.38	-0.15	13	5.43	-
Net change in cash and cash eq.	168.2%	15	-19.53	17	-170.96	75	-

Description	(%) Q/Q	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Change in inventories	-188.5%	-15.07	-4.57	-20.1	3.29	-16.65	-
Depreciation	10%	12	11	11	10	9.56	-
Unrealised forex losses/gains	-	-0.42	0	0	-0.1	0	-
Adjustments for interest income	-	0	0	0	0	2.59	-
Net Cashflows from Operations	22.7%	174	142	137	73	62	-
Dividends received	-0.3%	-56.29	-56.11	-52.67	-3.16	-3.82	-
Interest paid	2.4%	-0.21	-0.24	-0.16	-0.14	-0.09	-
Interest received	-16%	-1.47	-1.13	-1.12	-3.4	0.04	-
Income taxes paid (refund)	28.6%	28	22	27	16	21	-
Other inflows (outflows) of cash	-	-0.02	0	0	0	0	-
Net Cashflows From Operating Activities	41.9%	89	63	56	50	37	-
Proceeds from sales of PPE	-	0.04	0	-20.61	0.15	0	-
Purchase of property, plant and equipment	104.8%	44	22	0	23	11	-
Proceeds from sales of investment property	-13.6%	0	0.12	0.13	0	1.24	-
Purchase of investment property	-	0	0	0	0	21	-
Proceeds from sales of intangible assets	-	0	0	0	0	16	-
Purchase of intangible assets	7.6%	0.15	0.08	0.03	0.05	0.06	-
Dividends received	0%	56	56	53	3.16	3.82	-
Interest received	-64.1%	1.14	1.39	1.12	0.19	0	-
Other inflows (outflows) of cash	-27.2%	-47.27	-36.94	-40.17	-22.38	-3.93	-
Net Cashflows From Investing Activities	-1184.3%	-34.19	-1.74	-6.88	-42.35	-14.28	-
Proceeds from issuing shares	-61.3%	0	0.38	0	0.14	0.43	-
Proceeds from exercise of stock options	-	0.95	0	0	0	0	-
Repayments of borrowings	-	0	0	0.01	0	0.72	-
Payments of lease liabilities	-4900%	0	0.98	0.8	0.65	0.43	-
Dividends paid	1.8%	58	57	56	11	10	-
Interest paid	-	0	0	0.16	0.14	0.09	-
Other inflows (outflows) of cash	-	-1.02	0	0	-0.17	0	-
Net Cashflows from Financing Activities	-1.1%	-58.25	-57.63	-56.88	-11.99	-10.87	-
Net change in cash and cash eq.	-251.4%	-3.71	4.11	-7.95	-4.05	12	-

ADVENZYMES - Advanced Enzyme Technologies Limited Share Price

ADVENZYMES

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

ADVENZYMES

ADVENZYMES - Advanced Enzyme Technologies Limited Share Price

ADVENZYMES

Valuation

Fundamentals

Profitability

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

ADVENZYMES

Investor Care

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

What does Advanced Enzyme Technologies Limited do?

Important Disclosure & Data Context

Valuation

Fundamentals

Profitability

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

Investor Care

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

What does Advanced Enzyme Technologies Limited do?

Important Disclosure & Data Context